CTRI/2023/02/049508已完成不适用
Determination of the possible association between specific udal iyal (body constituents) with PAANDU (anaemia) - an observational clinical study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 96
- 试验地点
- 1
- 主要终点
- The possible association of Dhegi characterization in Paandu patients will be obtained based on odds ratio.
研究概览
简要总结
This Case control study will be conducted in National Institute of Siddha with Anemia patients. The Patients will be Selected based on Inclusion and exclusion criteria, 48 cases and 48 controls will be enrolled on this study. Dhegies questionarie will be asked to both cases and control. From that we will arrive which particular Dhegies are prone to Anemia.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with Paandu(anaemia) with Hb moderate(8.0-10.9)gm/dl to severe(lower than 8.0gm/dl).
排除标准
- •Patients not willing tosign in consent form.
- •Patients with chronic systemic illness.
- •Vulnerable groups (children, pregnanat women, cognitively impaired).
结局指标
主要结局
The possible association of Dhegi characterization in Paandu patients will be obtained based on odds ratio.
时间窗: 6 months
次要结局
- To Analyse the correlation of Naadi and Neikuri.(6 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A Study of NeoRecormon in Patients With Chronic Kidney Disease.AnemiaNCT00437723Hoffmann-La Roche90
已完成
不适用
A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) RegisterChronic Kidney DiseaseNCT05015998Astellas Pharma Europe Ltd.45,637
已完成
不适用
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney DiseaseChronic Kidney DiseaseAnemiaCardiomyopathyNCT00883415University of Maryland, Baltimore20
已完成
不适用
The Impact of Anemia of Chronic Disease on Chronic Obstructive Pulmonary Disease PatientsCOPDAnemiaNCT01033175Aristotle University Of Thessaloniki60
已完成
4 期
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®AnemiaNCT00117117Amgen2,423